Nomura Securities on U.S. Payments: Quarterly Spend Volume Monitor
Tweet
Share
E-mailGet Alerts MA Hot Sheet
Price: $573.10 -0.74%
Rating Summary:
43 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
43 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
Nomura Securities on U.S. Payments: Quarterly Spend Volume Monitor
Analyst, Bill Carcache, said, "We have identified the economic variables with the greatest predictive value for debit, credit, and total purchase volumes for the payment networks. We incorporate these variables into regressions to forecast what they’re telling us about Visa and MasterCard volumes for the June quarter. The overall US macro data we have seen this quarter point to low double-digit volume growth for MasterCard and mid single-digit volume growth for Visa. Our EPS revisions are therefore primarily driven by FX. For MasterCard (NYSE: MA), our 2Q12 / 2012 EPS estimates go to $5.57 / $22.23 (from $5.75 / $22.54). For Visa (NYSE: V), our 3Q12 / 2012 EPS estimates go to $1.42 / $5.98 (from $1.43 / $6.00). We’re leaving our 2013 EPS estimates, price targets, and ratings unchanged at this time. The recently announced merchant litigation settlement is one area that we expect will get lots of attention this quarter."
Analyst, Bill Carcache, said, "We have identified the economic variables with the greatest predictive value for debit, credit, and total purchase volumes for the payment networks. We incorporate these variables into regressions to forecast what they’re telling us about Visa and MasterCard volumes for the June quarter. The overall US macro data we have seen this quarter point to low double-digit volume growth for MasterCard and mid single-digit volume growth for Visa. Our EPS revisions are therefore primarily driven by FX. For MasterCard (NYSE: MA), our 2Q12 / 2012 EPS estimates go to $5.57 / $22.23 (from $5.75 / $22.54). For Visa (NYSE: V), our 3Q12 / 2012 EPS estimates go to $1.42 / $5.98 (from $1.43 / $6.00). We’re leaving our 2013 EPS estimates, price targets, and ratings unchanged at this time. The recently announced merchant litigation settlement is one area that we expect will get lots of attention this quarter."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sun Pharmaceutical Industries Ltd. (SUNP:IN) PT Raised to INR2,238 at Elara Securities India
- JPMorgan Downgrades Mankind Pharma Ltd (MANKIND:IN) to Neutral
- Kotak Upgrades Mahanagar Gas Limited (MAHGL:IN) to Reduce (3)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
